These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23176724)

  • 21. Molecular and clinical follow-up after treatment of multiple myeloma.
    Rasmussen T; Knudsen LM; Huynh TK; Johnsen HE
    Acta Haematol; 2004; 112(1-2):105-10. PubMed ID: 15179010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloma: its diagnosis and treatment.
    Campbell K
    Nurs Times; 2002 Jun 25-Jul 1; 98(26):38-40. PubMed ID: 12168212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple myeloma patient care: treatment options and nursing considerations.
    McGee L
    ONS Connect; 2007; 22(8 Suppl):67-8. PubMed ID: 17824572
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multiple myeloma].
    Peest D
    Ther Umsch; 1996 Feb; 53(2):147-51. PubMed ID: 8629265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic strategies and controversies in the treatment of multiple myeloma.
    Bladé J
    Pathol Biol (Paris); 1999 Feb; 47(2):192-8. PubMed ID: 10192888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
    Shimizu K;
    Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
    [No Abstract]   [Full Text] [Related]  

  • 27. Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia.
    Saini L; Minden MD; Schuh AC; Yee KW; Schimmer AD; Gupta V; Atenafu EG; Murray C; Nixon S; Brandwein JM
    Am J Hematol; 2012 Mar; 87(3):323-6. PubMed ID: 22213349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation.
    Galimberti S; Benedetti E; Morabito F; Petrini I; Battolla B; Papineschi F; Fazzi R; Ciabatti E; Martino M; Cuzzola M; Console G; Iacopino P; Petrini M
    Leuk Res; 2006 May; 30(5):529-35. PubMed ID: 16249028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High-dose melphalan in patients with multiple myeloma].
    Moreau P; Le Bonniec M; Harousseau JL
    Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined therapy of multiple myeloma: cytostatics and plasmapheresis].
    Górski J; Kicińska M
    Acta Haematol Pol; 1990; 21(2):166-72. PubMed ID: 2131716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current and future approaches to therapy for multiple myeloma].
    Nara N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation.
    Voena C; Malnati M; Majolino I; Fagà G; Montefusco V; Farina L; Santoro A; Ladetto M; Boccadoro M; Corradini P
    Bone Marrow Transplant; 2003 Oct; 32(8):791-3. PubMed ID: 14520423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interferon therapy in multiple myeloma].
    Micksche M
    Wien Med Wochenschr; 1993; 143(16-17):425-8. PubMed ID: 8273366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to treat multiple myeloma - a representative multicentre treatment survey.
    Knauf W; Kellermann L; Poenisch W; Einsele H; Straka C; Frohn C; Goldschmidt H
    Onkologie; 2010; 33(11):604-10. PubMed ID: 20975307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress made in myeloma research through multiple efforts.
    Mayer DK
    Clin J Oncol Nurs; 2011 Aug; 15 Suppl():4. PubMed ID: 21816705
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of multiple myeloma.
    Richards JD; Singer CR; Tobias JS
    Br J Hosp Med; 1987 May; 37(5):437, 440-2. PubMed ID: 2437986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
    Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
    Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide for multiple myeloma.
    Folkman J; Rogers MS
    N Engl J Med; 2006 Jun; 354(22):2389-90; author reply 2389-90. PubMed ID: 16738279
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple myeloma of the central nervous system: a clinicopathological review.
    Al-Sobhi E; Osoba AO; Karar A; Zuraiki AM
    East Mediterr Health J; 2009; 15(6):1570-9. PubMed ID: 20218151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.
    Tariman JD; Estrella SM
    Oncol Nurs Forum; 2005 Nov; 32(6):E127-38. PubMed ID: 16270103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.